Showing results (2091-2100 of 3,105) with videos related to

Sort By:
Pageof 311
Drug Safety|October 30, 2013
Empirical performance of the case-control method: lessons for developing a risk identification and analysis systemDavid Madigan, Martijn J Schuemie, Patrick B Ryan
Drug Safety|October 30, 2013
Empirical performance of the self-controlled case series design: lessons for developing a risk identification and analysis systemMarc A Suchard, Ivan Zorych, Shawn E Simpson, et al.
Drug Safety|October 30, 2013
Empirical performance of a self-controlled cohort method: lessons for developing a risk identification and analysis systemPatrick B Ryan, Martijn J Schuemie, David Madigan
Drug Safety|October 30, 2013
Empirical performance of LGPS and LEOPARD: lessons for developing a risk identification and analysis systemMartijn J Schuemie, David Madigan, Patrick B Ryan
Drug Safety|October 30, 2013
A comparison of the empirical performance of methods for a risk identification systemPatrick B Ryan, Paul E Stang, J Marc Overhage, et al.
Drug Safety|November 1, 2013
Postmenopausal estrogen therapy and risk of gallstone disease: a population-based case-control studyMaja Hellfritzsch Simonsen, Rune Erichsen, Trine Frøslev, et al.
Drug Safety|December 19, 2014
Causal assessment of pharmaceutical treatments: why standards of evidence should not be the same for benefits and harms?Barbara Osimani, Fiorenzo Mignini
Drug Safety|December 3, 2014
Aristolochic acid nephropathy: epidemiology, clinical presentation, and treatmentRandy L Luciano, Mark A Perazella
Drug Safety|March 5, 2016
Medication Errors: New EU Good Practice Guide on Risk Minimisation and Error PreventionThomas Goedecke, Kathryn Ord, Victoria Newbould, et al.
Drug Safety|November 9, 2015
Adverse Drug Reactions Reported to a National HIV & Tuberculosis Health Care Worker Hotline in South Africa: Description and Prospective Follow-Up of ReportsChristine Njuguna, Annemie Stewart, Johannes P Mouton, et al.
Pageof 311